Bradley Foster & Sargent’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-10,000
| Closed | -$15K | – | 468 |
|
2024
Q3 | $15K | Hold |
10,000
| – | – | ﹤0.01% | 457 |
|
2024
Q2 | $7.03K | Hold |
10,000
| – | – | ﹤0.01% | 444 |
|
2024
Q1 | $9.5K | Hold |
10,000
| – | – | ﹤0.01% | 439 |
|
2023
Q4 | $11.1K | Hold |
10,000
| – | – | ﹤0.01% | 426 |
|
2023
Q3 | $35.9K | Hold |
10,000
| – | – | ﹤0.01% | 429 |
|
2023
Q2 | $35.9K | Hold |
10,000
| – | – | ﹤0.01% | 429 |
|
2023
Q1 | $33.7K | Sell |
10,000
-2,000
| -17% | -$6.74K | ﹤0.01% | 426 |
|
2022
Q4 | $18.6K | Buy |
12,000
+2,000
| +20% | +$3.1K | ﹤0.01% | 423 |
|
2022
Q3 | $14K | Hold |
10,000
| – | – | ﹤0.01% | 419 |
|
2022
Q2 | $22K | Hold |
10,000
| – | – | ﹤0.01% | 433 |
|
2022
Q1 | $32K | Sell |
10,000
-250
| -2% | -$800 | ﹤0.01% | 466 |
|
2021
Q4 | $43K | Sell |
10,250
-23,990
| -70% | -$101K | ﹤0.01% | 445 |
|
2021
Q3 | $278K | Sell |
34,240
-6,500
| -16% | -$52.8K | 0.01% | 369 |
|
2021
Q2 | $308K | Buy |
40,740
+864
| +2% | +$6.53K | 0.01% | 356 |
|
2021
Q1 | $346K | Buy |
39,876
+736
| +2% | +$6.39K | 0.01% | 326 |
|
2020
Q4 | $312K | Hold |
39,140
| – | – | 0.01% | 332 |
|
2020
Q3 | $312K | Buy |
+39,140
| New | +$312K | 0.01% | 296 |
|
2020
Q1 | $254K | Sell |
32,890
-299
| -0.9% | -$2.31K | 0.01% | 299 |
|
2019
Q4 | $128K | Sell |
33,189
-12,308
| -27% | -$47.5K | ﹤0.01% | 353 |
|
2019
Q3 | $229K | Sell |
45,497
-73,254
| -62% | -$369K | 0.01% | 324 |
|
2019
Q2 | $785K | Sell |
118,751
-13,261
| -10% | -$87.7K | 0.03% | 230 |
|
2019
Q1 | $999K | Sell |
132,012
-17,966
| -12% | -$136K | 0.03% | 212 |
|
2018
Q4 | $1.21M | Buy |
149,978
+5,486
| +4% | +$44.3K | 0.05% | 188 |
|
2018
Q3 | $1.86M | Buy |
144,492
+4,926
| +4% | +$63.5K | 0.06% | 177 |
|
2018
Q2 | $1.59M | Buy |
+139,566
| New | +$1.59M | 0.06% | 189 |
|